Adverse Event
45
9
10
25
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 45 trials
100.0%
+13.4% vs benchmark
9%
4 trials in Phase 3/4
4%
1 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 25 completed trials
Clinical Trials (45)
Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis
Patient Safety Incidents in Coordinated Primary Care Teams: a Multi-method Study
Adverse Events Among Hospitalized Patients in China
PAUSE: Sick Day Medication Management Mobile App Study
Conscious Sedation for Transcatheter Aortic Valve Implantation
Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Human Milk Oligosaccharides (HMOs) - Post Marketing Study on Infants (NeHMO)
Can Sleep Apnea Screening Questionnaire Predict Adverse Events in Endoscopic Studies
Intramuscular Ketorolac at Two Single-Dose Regimens
Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort
Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients
Adverse Event Prediction in Geriatric Patients in the ED With Ultrasound
Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)
The Immune Assessment of PD-1 Antibody Therapy in Tumor
Older Emergency Department Users and Short-term Adverse Events at the Index Visit
Assessment of the Humanisation of Care in Hospitals in Andalusia-Spain
Early Versus Conventional Cessation of Hydrocortisone in Septic Shock
Comparison of the Sedation Effect of Esketamine and Sevoflurane for Pediatric Ophthalmological Procedure